[HTML][HTML] Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies

NK Farkhad, H Reihani, AA Moghadam… - Regenerative …, 2021 - Elsevier
The Covid-19 disease has recently become one of the biggest challenges globally, and
there is still no specific medication. Findings showed the immune system in severe Covid-19 …

[HTML][HTML] Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects

M Abdelgawad, NS Bakry, AA Farghali… - Stem cell research & …, 2021 - Springer
Abstract Novel coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus-2. The virus causes an exaggerated immune response, resulting in a …

[HTML][HTML] Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19

X Cheng, M Jiang, L Long, J Meng - Frontiers in Bioscience …, 2021 - imrpress.com
Background: Corona Virus Disease 2019 (COVID-19) is an acute respiratory infectious
disease caused by severe respiratory syndrome coronavirus 2 (SARS-CoV-2). The primary …

Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19

E Zendedel, L Tayebi, M Nikbakht… - Current Stem Cell …, 2024 - ingentaconnect.com
Mesenchymal Stem Cells (MSCs) are being investigated as a treatment for a novel viral
disease owing to their immunomodulatory, anti-inflammatory, tissue repair and regeneration …

Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action

S Sadeghi, S Soudi, A Shafiee, SM Hashemi - Life sciences, 2020 - Elsevier
The outbreak of COVID-19 in December 2019, has become an urgent and serious public
health emergency. At present, there is no effective treatment or vaccine for COVID-19 …

Mesenchymal stem cells in SARS-CoV-2 infection: A hype or hope

D Pal, J Goyal, U Sharma, A Sharma, S Prashar… - Life Sciences, 2021 - Elsevier
COVID-19 is a serious viral infection that struck the world in December 2019 starting from
Wuhan in China, spreading subsequently to all over the world. The disease has baffled …

[HTML][HTML] Immunomodulation and regenerative capacity of MSCs for long-COVID

XY Loke, SAM Imran, GJ Tye… - International Journal of …, 2021 - mdpi.com
The rapid mutation of the SARS-CoV-2 virus is now a major concern with no effective drugs
and treatments. The severity of the disease is linked to the induction of a cytokine storm that …

[HTML][HTML] Mesenchymal stem cells (MSCs) as a novel therapeutic option for nCOVID-19—a review

M Jeyaraman, R Somasundaram, TC Anudeep… - Open Journal of …, 2020 - scirp.org
The novel Coronavirus Disease (nCOVID-19) is a highly contagious viral infection which
emerged as “Pneumonia of Unknown Etiology” at Hubei province of Wuhan city in China …

Feasibility of mesenchymal stem cell therapy for COVID-19: a mini review

J Li, X Wang, N Li, Y Jiang, H Huang… - Current Gene …, 2020 - ingentaconnect.com
Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which
involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as …

[HTML][HTML] Stem cells therapy as a possible therapeutic option in treating COVID-19 patients

D Esquivel, R Mishra, P Soni, R Seetharaman… - Stem cell reviews and …, 2021 - Springer
An unfortunate emergence of a new virus SARS-CoV-2, causing a disease known as COVID-
19, has spread all around the globe and has caused a pandemic. It primarily affects the …